Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 151-157, November 2006

Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer

Radiation Oncology, Zurich University Hospital, Switzerland

Received 30 December 2005; received in revised form 26 June 2006; accepted 15 September 2006. published online 23 October 2006.

Abstract 

Background and purpose

To define the potential advantages of intensity-modulated radiotherapy (IMRT) applied using a non-coplanar dynamic arc technique for the treatment of head and neck cancer.

Materials and methods

External beam radiotherapy (EBRT) was planned in ten patients with head and neck cancer using coplanar IMRT and non-coplanar arc techniques, termed intensity modulated non-coplanar arc EBRT (INCA). Planning target volumes (PTV1) of first order covered the gross tumor volume and surrounding clinical target volume treated with 68–70Gy, whereas PTV2 covered the elective lymph nodes with 54–55Gy using a simultaneous internal boost. Treatment plan comparison between IMRT and INCA was carried out using dose–volume histogram and “equivalent uniform dose” (EUD).

Results

INCA resulted in better dose coverage and homogeneity of the PTV1, PTV2, and reduced dose delivered to most of the organs at risk (OAR). For the parotid glands, a reduction of the mean dose of 2.9 (±2.0) Gy was observed (p=0.002), the mean dose to the larynx was reduced by 6.9 (±2.9) Gy (p=0.003), the oral mucosa by 2.4 (±1.1) Gy (p<0.001), and the maximal dose to the spinal cord by 3.2 (±1.7) Gy (p=0.004). The mean dose to the brain was increased by 3.0 (±1.4) Gy (p=0.002) and the mean lung dose increased by 0.2 (±0.4) Gy (p=0.87). The EUD suggested better avoidance of the OAR, except for the lung, and better coverage and dose uniformity were achieved with INCA compared to IMRT.

Conclusion

Dose delivery accuracy with IMRT using a non-coplanar dynamic arc beam geometry potentially improves treatment of head and neck cancer.

Keywords: Intensity-modulated radiotherapy, Non-coplanar arc therapy, External beam radiotherapy, Head and neck cancer, Toxicity, Xerostomia, IMRT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(06)00481-6

doi:10.1016/j.radonc.2006.09.004

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 151-157, November 2006